SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 419.72 |
| Enterprise Value ($M) | 257.45 |
| Book Value ($M) | 216.13 |
| Book Value / Share | 3.03 |
| Price / Book | 1.94 |
| NCAV ($M) | 202.69 |
| NCAV / Share | 2.84 |
| Price / NCAV | 2.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.22 |
| Return on Assets (ROA) | 0.20 |
| Return on Equity (ROE) | 0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.28 |
| Current Ratio | 8.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 233.62 |
| Assets | 247.07 |
| Liabilities | 30.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 138.72 |
| Operating Income | 69.98 |
| Net Income | 59.21 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 48.76 |
| Cash from Investing | -0.04 |
| Cash from Financing | -43.46 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 4.70 | -15.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 87,737 | 507,458 | 17.29 | |
| 198,469 | 498,574 | 39.81 | |
| 103,754 | 363,014 | 28.58 | |
| 76,529 | 332,880 | 22.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SAGE – Sage Therapeutics, Inc. | SCYX – SCYNEXIS, Inc. |
| SGMT – Sagimet Biosciences Inc. | SKYE – Skye Bioscience, Inc. |
| SMMT – Summit Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io